Lexeo Therapeutics, Inc. (NASDAQ:LXEO) Receives $22.80 Consensus Target Price from Analysts
Shares of Lexeo Therapeutics, Inc. (NASDAQ:LXEO – Get Free Report) have been given an average rating of “Buy” by the six ratings firms that are currently covering the company, MarketBeat reports. Five analysts have rated the stock with a buy recommendation and one has issued a strong buy recommendation on the company. The average 1 […]
Shares of Lexeo Therapeutics, Inc. (NASDAQ:LXEO – Get Free Report) have been given an average rating of “Buy” by the six ratings firms that are currently covering the company, MarketBeat reports. Five analysts have rated the stock with a buy recommendation and one has issued a strong buy recommendation on the company. The average 1 […]
